Status:
COMPLETED
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
Eligibility Criteria
Inclusion
- Clinical diagnosis of glaucoma or ocular hypertension in both eyes
- Patient requires IOP-lowering drug in both eyes
Exclusion
- Uncontrolled medical conditions
- Ocular seasonal allergies within the past 2 years
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
561 Patients enrolled
Trial Details
Trial ID
NCT00300443
Start Date
December 1 2005
End Date
June 1 2007
Last Update
May 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Newport Beach, California, United States